Successful Treatment of Prolonged, Severe Coronavirus Disease 2019 Lower Respiratory Tract Disease in a B cell Acute Lymphoblastic Leukemia Patient With an Extended Course of Remdesivir and Nirmatrelvir/Ritonavir

Affiliations

• ¹ Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington, USA.
• ² Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.
• ³ Division of General Internal Medicine, Department of Medicine, University of Washington, Seattle, Washington, USA.
• ⁴ Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.
• ⁵ Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, Washington, USA.
• ⁶ Division of Hematology, Department of Medicine, University of Washington, Seattle, Washington, USA.
• ⁷ Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, University of Washington, Seattle, Washington, USA.
• ⁸ Department of Laboratory Medicine, University of Washington, Seattle, Washington, USA.
• ⁹ Department of Global Health, University of Washington, Seattle, Washington, USA.
• ¹⁰ Pfizer, New York, NY, USA.